Novel human calcium dependent proteases, polynucleotides encoding the same, and uses thereof

a polynucleotide and protein technology, applied in the field of discovery, identification, and characterization of novel human polynucleotides encoding proteins, can solve problems such as unsatisfactory use, and achieve the effects of increasing or decreasing nhp activity, reducing white blood cell count, and increasing or decreasing white blood cell coun

Inactive Publication Date: 2004-10-07
DONOHO GREGORY +5
View PDF57 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0012] The present invention also provides novel methods and compositions that can be used to facilitate drug discovery, drug development, and / or as treatments of conditions such as reduced white blood cell count, and the complications resulting therefrom. The present invention is based on the identification and novel functional characterization of the NHPs described herein.

Problems solved by technology

Although treatments for neutropenia currently exist in the art, they are not ideal for use in all circumstances, and are actually contraindicated in certain patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] The NHPs, described for the first time herein, are novel proteins that are expressed in, inter alia, human cell lines, and human prostate and testis cells. The described sequences were compiled from gene trapped cDNAs and clones isolated from a human testis cDNA library (Edge Biosystems, Gaithersburg, Md.).

[0020] The present invention encompasses the nucleotides presented in the Sequence Listing, host cells expressing such nucleotides, the sexpression products of such nucleotides, and: (a) nucleotides that encode mammalian homologs of the described polynucleotides, including the specifically described NHPs, and the NHP products; (b) nucleotides that encode one or more portions of the NHPs that correspond to functional domains, and the polypeptide products specified by such nucleotide sequences, including, but not limited to, the novel regions of any active domain(s); (c) isolated nucleotides that encode mutant versions, engineered or naturally occurring, of the described NHPs...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
body weightaaaaaaaaaa
timeaaaaaaaaaa
timeaaaaaaaaaa
Login to view more

Abstract

Novel human polunucleotide and polypeptide sequences are disclosed that can be used in therapeuutic, diagnostic, and pharmacogenomic applications.

Description

[0001] The present application is a continuation-in-part of co-pending U.S. application Ser. No. 09 / 653,839, filed on Sep. 1, 2000, which claims the benefit of U.S. Provisional Application Serial No. 60 / 152,057, filed Sep. 2, 1999, both of which are herein incorporated by reference in their entirety.1.0 INTRODUCTION[0002] The present invention relates to the discovery, identification, and characterization of novel human polynucleotides encoding proteins that share sequence similarity with human calcium dependent proteases, specifically calpains. The invention encompasses the described polynucleotides, host cell expression systems, the encoded proteins, fusion proteins, polypeptides and peptides, antibodies to the encoded proteins and peptides, and genetically engineered animals that either lack or overexpress the disclosed polynucleotides, antagonists and agonists of the proteins, and other compounds that modulate the expression or activity of the proteins encoded by the disclosed p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N9/64
CPCC12N9/6472
Inventor DONOHO, GREGORYTURNER, C. ALEXANDER JR.NEHLS, MICHAEL C.FRIEDRICH, GLENNZAMBROWICZ, BRIANSANDS, ARTHUR T.
Owner DONOHO GREGORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products